Atlas Arteria Group's (ASX: ALX) independent directors urge shareholders to reject IFM’s takeover offer, citing ...
Atlas Arteria has recommended shareholders reject IFM's hostile takeover bid, calling it "too low, opportunistic and highly conditional".
Atlas Arteria’s independent directors have urged investors to reject IFM Investors’ $6.89 billion hostile takeover bid, calling it opportunistic, undervalued, and highly conditional. The offer of ...
Atlas Arteria shares soared more than 14% after IFM Investors launched an unsolicited $6.9 billion takeover bid. The offer is $4.75 per share in cash, with a conditional increase to $5.10 if IFM’s ...